Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial have?
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial has 209 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial published?
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial has 2024 year in the ScholarIQ index.
What is the open-access status of Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial?
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial?
The DOI for Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial is on the source record.
What is the PMID of Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial?
The PMID for Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial is on the source record.
What is the OpenAlex record for Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial?
The OpenAlex for Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial is on the source record.